Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anaphylactic shock | x | x | x | x | x | x | x | ||||
Angioedema | x | x | x | x | x | ||||||
Cold urticaria | x | x | x | x | |||||||
Conjunctivitis | x | x | x | ||||||||
Conjunctivitis allergic | x | x | x | x | |||||||
Hypersensitivity | x | x | x | x | x | x | x | ||||
Rhinitis allergic | x | x | x | ||||||||
Seasonal allergy | x | x | x | x | |||||||
Urticaria | x | x | x | x | x | x | x | ||||
Urticaria physical | x | x | x | x | |||||||
Vasomotor rhinitis | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |